RKVTDRAKOVINA THERAPEUTICS INC

About RAKOVINA THERAPEUTICS INC (RKVTD)

RAKOVINA THERAPEUTICS INC (RKVTD) is a company headquartered in Vancouver, BC, Canada whose shares trade over-the-counter on the Pink tier.

Rakovina Therapeutics Inc. engages in the research and development of new cancer treatments based on novel series of small-molecule DNA-damage response inhibitors (DDRi). Its preclinical product pipeline include kt-2000, a next generation oral targeted small molecule PARP inhibitors; kt-3000, a bi-functional small-molecule drug candidate; and kt-4000, a DNA-damaging DDR inhibitors.

RKVTD key facts

Ticker symbol

RKVTD

Market tier

Pink

Headquarters

Vancouver, BC, Canada

Estimated market cap

$8.43M (as of Aug 1, 2025)

Shares outstanding

21,148,039

Reporting standard

International Reporting: TSX Venture Exchange

Audit status

Audited

Fiscal year end

12/31

Explore more: Pink stocks · OTC stocks starting with R